When pharmacologically targeting the NF-κB signaling pathway, it is also important to consider that NF-κB plays an important role in the immune response, and long-term use of NF-κB inhibitors can lead to immunodeficiency [72,124]. Here, NFKB1 is linked to immune system disorder.